Skip to main
IMAX

IMAX (IMAX) Stock Forecast & Price Target

IMAX (IMAX) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 38%
Hold 15%
Sell 0%
Strong Sell 0%

Bulls say

Imax is viewed positively because its record $712 million global box office in 3Q, led by The Odyssey’s nearly $400 million contribution, shows powerful demand for premium IMAX presentations and strong operating leverage. The company’s expected Q3 revenue of $161 million, EBITDA of $84 million to $91 million, and EPS of $0.98, alongside a 9.4% share of domestic box office versus a 5% average in 2025 and 4% in 2023–2024, indicate that its branded platform is gaining share and converting attendance into earnings efficiently. Its expanding 2026–2027 slate, deep studio relationships, and ability to pivot programming across local language, alternative content, and major tentpoles support further network growth, margin expansion, and durable cash generation.

Bears say

Imax is exposed to multiple fundamental weaknesses that pressure its long-term earnings quality, including weak macro conditions, uncertain box-office demand, and secular shifts in how movies are watched. Its dependence on blockbuster tent-pole films, commercial exhibitors, and the success of IMAX DMR content makes revenue vulnerable if audience demand softens or exhibitors reduce purchases, leases, or revenue-sharing activity. Added risks from China regulation, competitive encroachment, technology adoption uncertainty, IP protection issues, and variable quarterly operating results further support a negative outlook.

IMAX (IMAX) has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 38% recommend Buy, 15% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IMAX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IMAX (IMAX) Forecast

Analysts have given IMAX (IMAX) a Buy based on their latest research and market trends.

According to 13 analysts, IMAX (IMAX) has a Buy consensus rating as of Oct 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $57.69, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $57.69, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IMAX (IMAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.